Filing Details
- Accession Number:
- 0001209191-10-015400
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-03-08 12:00:00
- Reporting Period:
- 2010-03-04
- Filing Date:
- 2010-03-08
- Accepted Time:
- 2010-03-08 20:41:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 353569 | Quidel Corp | QDEL | In Vitro & In Vivo Diagnostic Substances (2835) | 942573850 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1187716 | D Ph Lake Mary Polan | 10165 Mckellar Court San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-03-04 | 20,000 | $5.50 | 34,930 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2010-03-04 | 20,000 | $4.26 | 54,930 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2010-03-04 | 10,000 | $5.45 | 64,930 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-03-04 | 13,400 | $13.64 | 51,530 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-03-05 | 5,000 | $13.71 | 46,530 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option | Disposition | 2010-03-04 | 20,000 | $0.00 | 20,000 | $5.50 |
| Common Stock | Non-Qualified Stock Option | Disposition | 2010-03-04 | 20,000 | $0.00 | 20,000 | $4.26 |
| Common Stock | Non-Qualified Stock Option | Disposition | 2010-03-04 | 10,000 | $0.00 | 10,000 | $5.45 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2010-11-01 | No | 4 | M | Direct | |
| 0 | 2011-05-23 | No | 4 | M | Direct | |
| 0 | 2013-05-21 | No | 4 | M | Direct |
Footnotes
- Reporting Person sold these securities in payment of the exercise price of the options listed on Table II.
- The weighted average purchase price for these transactions was $13.6366 per share, with a range of $13.56 to $13.82 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price.
- The weighted average purchase price for these transactions was $13.7135 per share, with a range of $13.65 to $13.87 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price.
- Twenty-five percent (25%) of the shares vested on the first anniversary date of the grant date and the remaining shares vested quarterly at a rate of 6.25% per quarter.
Billionaire Hedge Funds
